Several ATP-binding cassette transporters identified in the transcriptomic analysis have been reported to associate with the multidrug resistance profile of AML patients [35], representing a major challenge for overcoming the low efficacy of therapeutic strategies. Here, ABCA4 is linked to acute myeloid leukemia.